Position in MNKD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$0
-$39,935 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Derivatives in MNKD
reported options exposure · as of Jun 30, 2026CallValue
$1,065,000
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Stonepine Capital Management, LLC holds $107,440,851 across 61 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VSTM |
Verastem, Inc.
|
3,349,627 | $12,795,575 | |
| 2 | TENX |
Tenax Therapeutics, Inc.
|
660,000 | $9,603,000 | |
| 3 | NKTR |
Nektar Therapeutics
|
120,654 | $8,422,855 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
740,000 | $6,193,800 | |
| 5 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,072,648 | |
| 6 | ELOX |
Eloxx Pharmaceuticals, Inc.
|
397,160 | $5,512,580 | |
| 7 | KZIA |
Kazia Therapeutics Ltd
|
345,179 | $4,860,120 | |
| 8 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
425,000 | $3,986,500 |
All Filings in MNKD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,065,000 | 250,000 | Call | Sole | 2026-08-17 | |
| 2026-03-31 | $39,935 | 16,300 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $1,225,000 | 500,000 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $489,655 | 86,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $846,145 | 157,569 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||